Cancer in infants, children, teenagers and young adults is
more common than most people realize and statistics are very
the United States, cancer is the number 1 killer of children by
year, about 3,000 children die from Cancer – more than from
Asthma, Diabetes, Cystic Fibrosis, Congenital Anomalies, and
Pediatric AIDS combined.
- Currently, one in every 330 Americans develops cancer
during childhood or adolescence, before the age of 20. On the
average, 46 children and adolescents are diagnosed with cancer
every weekday in the United States.
- Nationally, the incidence of cancer in children is more
than 20 times greater than the incidence of AIDS in
- Pediatric cancer funding is nominal in comparison to other
more publicized diseases, such as pediatric AIDS or juvenile
diabetes, which increase in awareness each year.
- Awareness of much needed funding for Pediatric Cancer is
virtually absent from the public eye due to lack of media
attention. For example, the funding for pediatric AIDS is four
times greater than the funding for pediatric cancer, yet in
comparison, twice as many children die of cancer in one month as
do die of AIDS in one year.
cases of pediatric cancer are increasing at a rate of 1% every
year, while funding for research continues to be minimal.
- Cancer during adolescence and young adulthood is increasing
and unexplained; progress in treating cancer in these age groups
- Sadly, more than 60% of the American public knows little,
if any, about pediatric cancer.
- Although cancer survival among children, in particular,
those with Acute Lymphocytic Leukemia (ALL), has risen, there are
still several childhood cancers that continue to have a very poor
prognosis; including brain stem tumors, metastatic sarcomas,
relapsed Acute Lymphoblastic Leukemia, relapsed Non-Hodgkin's
Lymphoma and Juvenile Myelomonocytic Leukemia.
- Cancer in childhood occurs regularly, randomly and spares
no ethnic group, socioeconomic class, or geographic region.
number of the advances in adult cancer treatment are due to
breakthroughs in childhood cancer research.
“The payback for the investment (in childhood cancer) is
immense,” according to Doctor G. Denman Hammond, Founder of the
National Childhood Cancer Foundation “More value-added can be
achieved for every dollar invested in pediatric cancer research than
in most if not virtually all other cancer research endeavors”.
facts demonstrate the dire need for increased awareness and funding
toward childhood cancer research now.
Cooperative research is essential to advancing treatments
and cures for childhood cancer.
- Research protocols that compare the best-known standard
treatment to newly developed treatments have resulted in literally
all of the important improvements in treating childhood
than 235 childhood cancer institutions and 3,000 individual
investigators throughout North America participate in the
Children’s Oncology Group, to share and extend the knowledge and
expertise that leads to improved treatments and cures for
care of more than 40,000 young cancer patients is currently
managed according to Children’s Oncology Group protocols,
providing these patients with the most current and technologically
advanced treatment available.
Children’s Oncology Group is devoted to the study and development
of new treatments and cures for the cancers of infants, children,
adolescents and young adults. Research is conducted on the biology
of these cancers, their causes, and the long-term follow-up of
cured patients into adult life.
a difference, cooperative research is crucial. We intend to support
the efforts of the Children’s Oncology Group and that of the
National Childhood Cancer Foundation, as well as other organizations
fighting for a better tomorrow for young victims of cancer.
join us in taking steps forward that lead to the ultimate goal of
being able to offer every child with cancer a better chance for a